Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx حسب Juan Chen (61123)

"…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…"

An infographic outlining the data used for each analysis. حسب Shelby L. Sturrock (10751675)

الموضوعات:

Model-averaged coefficients, significance, and relative importance (RI) of the predictor variables for the GLMMs to evaluate effects on: (A) overall pollinator abundance; (B) fruit... حسب Carmelo Gómez-Martínez (9384385)

S1 Data - حسب Miki Doi (15347878)

الموضوعات:

S1 Fig - حسب Miki Doi (15347878)

الموضوعات:

Semiannual analysis of monthly use of sterile blood transfer devices. حسب Miki Doi (15347878)

الموضوعات:

Semiannual analysis of monthly use of skin disinfection swab sets in the hospital. حسب Miki Doi (15347878)

الموضوعات:

Changes in the monthly contamination rate (per set) in blood culture (BC). حسب Miki Doi (15347878)

الموضوعات:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

"…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"

A representative ultrasound axis image. حسب Eun-Seon Yang (19751340)

الموضوعات:

BMI groups by SES. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part2. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for HSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for overall population. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part1. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of HSES/LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of overall population. حسب Krystal Hunter (6820052)

الموضوعات: